The most comprehensive study, published in BioMed Research International (2021), found that 5-amino-1MQ treatment "reverses diet-induced obesity and related T2D" in obese mice
individuals may experience positive outcomes, but large-scale clinical evidence is limited
Enhanced Energy Expenditure and Fat Oxidation Studies show AOD9604 increases overall energy expenditure and fat oxidation rates independent of direct -AR activation [1]
Long-term use should be approached cautiously because some patients report mild side effects like nausea or injection site discomfort, and research on prolonged use is limited. To minimize the risk of adverse reactions, always get the injections from a registered physician
(4) Heike Stier, Evert Vos, David Kenley (2013) Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans Journal of Endocrinology and Metabolism, 2013, Volume 3 (Issue 1-2), Pages 7-15